Genomic Health, Inc. Company Profile | GHDX Company Information

viningocouqyl1601.blogspot.com
Genomic Health, a life sciencr company founded in August of 2000 and located inRedwood City, California, is committed to improvintg the quality of cancer treatment decisions througjh the research, development and commercializationh of genomic-based clinical laboratory To that end, the companyh conducts sophisticated genomic research to develop clinically-validatedd molecular diagnostics which providre individualized information on respons e to certain types of therapy, as well as the likelihood of diseases recurrence. These diagnostic technologies generatee information that healthcare providers and patients can use in makinbgtreatment decisions.
The pioneering work of Genomi c Health in molecular diagnostics has led to the Oncotype DX BreastCancef Assay, a laboratory test that analyzes the expression level of 21 genes in a woman's breast tumor It is the first and only gene expressionb test that has demonstrated the ability to predict a patient'sd likelihood to benefit from chemotherapy as well as her risk of experiencinvg a disease recurrence. Oncotype DX is recommendecd in both the American Societgy of ClinicalOncology (ASCO) and National Comprehensive Cancedr Network (NCCN) clinical practics guidelines, including it in the standardd of care for the majority of early-stage breast cancer patients. ...